Protagonist Therapeutics, Inc. (PTGX) financial statements (2022 and earlier)

Company profile

Business Address 7707 GATEWAY BLVD., SUITE 140
NEWARK, CA 94560-1160
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments326,900305,809133,01782,233144,00177,599
Cash and cash equivalents123,665117,35833,00682,233106,02921,084
Short-term investments203,235188,451100,011 37,97256,515
Restricted cash and investments 1010101010
Receivables5,3333,8217,4996,5113,163 
Prepaid expense3,2612,4492,2181,443378 
Other current assets    1,071906
Other undisclosed current assets5,2423,5172,56747,3062,3244,729
Total current assets:340,736315,606145,311137,503150,94783,244
Noncurrent Assets
Operating lease, right-of-use asset4,9364,9506,042
Property, plant and equipment1,7981,4621,681861879562
Long-term investments and receivables 2,000  11,45810,150
Long-term investments 2,000  11,45810,150
Restricted cash and investments225450450450450 
Deferred income tax assets  1,433
Other noncurrent assets     34
Deferred tax assets, net658  
Total noncurrent assets:6,9598,8629,6061,96912,78710,746
TOTAL ASSETS:347,695324,468154,917139,472163,73493,990
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities39,31621,57315,15016,87410,8036,435
Accounts payable1,6003,0752,7905,7111,2571,163
Accrued liabilities37,71618,49812,36011,1639,5465,272
Deferred revenue1,60114,47717,738
Debt  1,256   
Due to related parties8992,7321,2621,061  
Contract with customer, liability8,223
Other undisclosed current liabilities2,2001,459  31,752 
Total current liabilities:44,01640,24135,40626,15842,5556,435
Noncurrent Liabilities
Long-term debt and lease obligation3,6584,5005,961   
Operating lease, liability3,6584,5005,961
Liabilities, other than long-term debt 12123,792799547 
Deferred revenue and credits547 
Deferred revenue  23,792
Deferred rent credit   799
Other liabilities 121    
Other undisclosed noncurrent liabilities(3,658) 9,794   
Total noncurrent liabilities:3,6584,62139,547799547 
Total liabilities:47,67444,86274,95326,95743,1026,435
Stockholders' equity
Stockholders' equity attributable to parent300,021279,60679,964112,515120,63287,555
Additional paid in capital709,682563,389297,846253,222222,188152,393
Accumulated other comprehensive income (loss)(299)28(221)(233)(6)(245)
Accumulated deficit(409,362)(283,811)(217,661)(140,474)(101,550)(64,593)
Total stockholders' equity:300,021279,60679,964112,515120,63287,555
TOTAL LIABILITIES AND EQUITY:347,695324,468154,917139,472163,73493,990

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues27,357896430,92520,063 
Revenue, net20,063 
Sublease income918964
Gross profit:27,357896430,92520,063 
Operating expenses(153,202)(93,144)(80,752)(73,194)(57,960)(32,666)
Other undisclosed operating income 28,539167   
Operating loss:(125,845)(64,516)(80,521)(42,269)(37,897)(32,666)
Nonoperating income2948542,8122,546940208
Investment income, nonoperating4439002,8132,546940242
Other nonoperating expense(149)(46)(1)  (34)
Interest and debt expense (1,183)(169)   
Loss from continuing operations before income taxes:(125,551)(64,845)(77,878)(39,723)(36,957)(32,458)
Income tax expense (benefit) (1,305)691(799)  
Loss before gain (loss) on sale of properties:(125,551)(66,150)(77,187)(40,522)(36,957)(32,458)
Other undisclosed net income   1,598  
Net loss:(125,551)(66,150)(77,187)(38,924)(36,957)(32,458)
Other undisclosed net loss attributable to parent     (4,719)
Net loss attributable to parent:(125,551)(66,150)(77,187)(38,924)(36,957)(37,177)
Preferred stock dividends and other adjustments     (558)
Net loss available to common stockholders, diluted:(125,551)(66,150)(77,187)(38,924)(36,957)(37,735)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(125,551)(66,150)(77,187)(38,924)(36,957)(32,458)
Other comprehensive loss     (143)
Comprehensive loss:(125,551)(66,150)(77,187)(38,924)(36,957)(32,601)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(327)24912(227)239(4,719)
Comprehensive loss, net of tax, attributable to parent:(125,878)(65,901)(77,175)(39,151)(36,718)(37,320)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: